Antibody Therapeutics Inc. has disclosed integrin receptor antagonists reported to be useful for the treatment of pulmonary fibrosis, renal fibrosis and hepatic fibrosis.
The scientists' new data show that paxillin binds directly to the intracellular part of integrin. It clings to the receptor, so to speak. Analysis of the 3D structure reveals an important piece of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback